Raymond James & Associates Conmed Corp Transaction History

Raymond James & Associates

$150 Billion
Q2 2024

A detailed history of Raymond James & Associates transactions in Conmed Corp stock. As of the latest transaction made, Raymond James & Associates holds 83,244 shares of CNMD stock, worth $6.19 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

83,244

Previous 84,635 1.64%

Holding current value

$6.19 Million

Previous $6.78 Million 14.86%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 19, 2024	SELL	$61.9 - $80.36 $86,102 - $111,780	-1,391 Reduced 1.64%	83,244 $5.77 Million
Q1 2024 Apr 22, 2024	BUY	$75.36 - $112.51 $318,848 - $476,029	4,231 Added 5.26%	84,635 $6.78 Million
Q4 2023 Jan 16, 2024	SELL	$91.3 - $115.05 $233,271 - $293,952	-2,555 Reduced 3.08%	80,404 $8.81 Million
Q3 2023 Oct 24, 2023	BUY	$97.55 - $135.91 $207,879 - $289,624	2,131 Added 2.64%	82,959 $8.37 Million
Q2 2023 Jul 25, 2023	SELL	$102.55 - $136.38 $2.27 Million - $3.02 Million	-22,165 Reduced 21.52%	80,828 $11 Million
Q1 2023 Apr 14, 2023	BUY	$89.75 - $107.27 $920,745 - $1.1 Million	10,259 Added 11.06%	102,993 $10.7 Million
Q4 2022 Feb 08, 2023	SELL	$72.84 - $94.04 $246,417 - $318,137	-3,383 Reduced 3.52%	92,734 $8.22 Million
Q3 2022 Oct 25, 2022	SELL	$77.78 - $103.92 $632,818 - $845,493	-8,136 Reduced 7.8%	96,117 $7.71 Million
Q2 2022 Aug 12, 2022	SELL	$88.23 - $154.18 $82,053 - $143,387	-930 Reduced 0.88%	104,253 $9.98 Million
Q1 2022 May 11, 2022	BUY	$121.88 - $150.0 $281,420 - $346,350	2,309 Added 2.24%	105,183 $15.6 Million
Q4 2021 Feb 08, 2022	SELL	$129.86 - $157.03 $90,252 - $109,135	-695 Reduced 0.67%	102,874 $14.6 Million
Q3 2021 Nov 02, 2021	BUY	$122.87 - $139.12 $1.42 Million - $1.6 Million	11,532 Added 12.53%	103,569 $13.6 Million
Q2 2021 Aug 11, 2021	BUY	$128.08 - $145.09 $2,049 - $2,321	16 Added 0.02%	92,037 $12.6 Million
Q1 2021 May 14, 2021	BUY	$111.35 - $130.59 $513,546 - $602,281	4,612 Added 5.28%	92,021 $12 Million
Q4 2020 Feb 12, 2021	BUY	$77.7 - $112.82 $179,253 - $260,275	2,307 Added 2.71%	87,409 $9.79 Million
Q3 2020 Nov 04, 2020	SELL	$69.87 - $89.2 $152,456 - $194,634	-2,182 Reduced 2.5%	85,102 $6.7 Million
Q2 2020 Jul 28, 2020	BUY	$50.31 - $81.76 $605,329 - $983,736	12,032 Added 15.99%	87,284 $6.28 Million
Q1 2020 Apr 21, 2020	BUY	$39.81 - $112.01 $1.12 Million - $3.16 Million	28,177 Added 59.86%	75,252 $4.31 Million
Q4 2019 Feb 12, 2020	BUY	$93.31 - $116.55 $82,579 - $103,146	885 Added 1.92%	47,075 $5.26 Million
Q3 2019 Nov 07, 2019	BUY	$83.97 - $102.19 $412,628 - $502,161	4,914 Added 11.91%	46,190 $4.44 Million
Q2 2019 Aug 06, 2019	BUY	$78.27 - $86.94 $1.03 Million - $1.14 Million	13,107 Added 46.53%	41,276 $3.53 Million
Q1 2019 May 06, 2019	BUY	$60.79 - $83.18 $1.71 Million - $2.34 Million	28,169 New	28,169 $2.34 Million

Others Institutions Holding CNMD

# of Institutions

307

Shares Held

35.5M

Call Options Held

44.6K

Put Options Held

114K

View Full List

About CONMED Corp

Ticker CNMD
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 30,482,400
Market Cap $2.27B
Description
CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide uni...

More about CNMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Account

Raymond James & Associates Conmed Corp Transaction History